ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleury, B
Right arrow Articles by Guilleminault, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fleury, B
Right arrow Articles by Guilleminault, C
Eur Respir J 1996; 9: 2356-2359
Copyright © ERS Journals Ltd 1996

Original Articles

Objective patient compliance in long-term use of nCPAP

B Fleury, D Rakotonanahary, C Hausser-Hauw, B Lebeau, and C Guilleminault

Concerns remain regarding patient compliance with nasal continuous positive airway pressure (nCPAP). Poor objective compliance during the first months of treatment has been reported, but no data are available among chronically treated patients. Use of nCPAP, in 17 chronically treated obstructive sleep apnoea patients (820+/-262 days) was evaluated objectively using a pressure monitor (MC+; Sefam, France). Two consecutive recording periods of 30 sessions of treatment were scheduled at the patient's home. To minimize the potential bias caused by the introduction of the monitor, only the pressure data obtained at the end of the second period of recording (T2) were analysed. During the 28.1+/-2.6 monitored days, the mean effective daily rate of use was 7.1+/-1.1 h, 97% of the rate indicated by the standard in-built time counter. The prescribed pressure was observed during 95% of the machine run time. The nCPAP system was used for 94% of the monitored days. Sixty percent of the patients used their device every day. These preliminary results suggest that, contrary to reported compliance during the early period of the treatment, objective use of nasal continuous positive airway pressure therapy in chronically treated patients is satisfactory.


This article has been cited by other articles:


Home page
 ChestHome page
P. Lloberes, S. Marti, G. Sampol, A. Roca, T. Sagales, X. Munoz, and M. Ferrer
Predictive Factors of Quality-of-Life Improvement and Continuous Positive Airway Pressure Use in Patients With Sleep Apnea-Hypopnea Syndrome: Study at 1 Year
Chest, October 1, 2004; 126(4): 1241 - 1247.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Gagnadoux, X.L. Nguyen, D. Rakotonanahary, S. Vidal, and B. Fleury
Wrist-actigraphic estimation of sleep time under nCPAP treatment in sleep apnoea patients
Eur. Respir. J., June 1, 2004; 23(6): 891 - 895.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
B. Fleury, D. Rakotonanahary, B. Petelle, G. Vincent, N. P. Fleury, B. Meyer, and B. Lebeau
Mandibular Advancement Titration for Obstructive Sleep Apnea: Optimization of the Procedure by Combining Clinical and Oximetric Parameters
Chest, May 1, 2004; 125(5): 1761 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. Oksenberg, I. Khamaysi, D. S. Silverberg, and A. Tarasiuk
Association of Body Position With Severity of Apneic Events in Patients With Severe Nonpositional Obstructive Sleep Apnea
Chest, October 1, 2000; 118(4): 1018 - 1024.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. Jokic, A. Klimaszewski, M. Crossley, G. Sridhar, and M. F. Fitzpatrick
Positional Treatment vs Continuous Positive Airway Pressure in Patients With Positional Obstructive Sleep Apnea Syndrome
Chest, March 1, 1999; 115(3): 771 - 781.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the European Respiratory Society.